ES8605771A1 - Procedimiento para preparar un polipeptido - Google Patents

Procedimiento para preparar un polipeptido

Info

Publication number
ES8605771A1
ES8605771A1 ES542310A ES542310A ES8605771A1 ES 8605771 A1 ES8605771 A1 ES 8605771A1 ES 542310 A ES542310 A ES 542310A ES 542310 A ES542310 A ES 542310A ES 8605771 A1 ES8605771 A1 ES 8605771A1
Authority
ES
Spain
Prior art keywords
formula
preparation
group
separation
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542310A
Other languages
English (en)
Spanish (es)
Other versions
ES542310A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES542310A0 publication Critical patent/ES542310A0/es
Publication of ES8605771A1 publication Critical patent/ES8605771A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES542310A 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido Expired ES8605771A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES542310A0 ES542310A0 (es) 1985-12-16
ES8605771A1 true ES8605771A1 (es) 1985-12-16

Family

ID=25820510

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Expired ES8605770A1 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Expired ES8605770A1 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado

Country Status (18)

Country Link
US (1) US4668662A (OSRAM)
EP (1) EP0158986B1 (OSRAM)
JP (1) JP2552263B2 (OSRAM)
KR (1) KR930000054B1 (OSRAM)
AR (1) AR242800A1 (OSRAM)
AU (1) AU580295B2 (OSRAM)
CA (1) CA1271298A (OSRAM)
DE (2) DE3438296A1 (OSRAM)
DK (1) DK171824B1 (OSRAM)
ES (3) ES8605771A1 (OSRAM)
FI (1) FI851521A7 (OSRAM)
GR (1) GR850942B (OSRAM)
HU (1) HU198085B (OSRAM)
IE (1) IE60581B1 (OSRAM)
IL (1) IL74948A (OSRAM)
NO (1) NO851535L (OSRAM)
PT (1) PT80301B (OSRAM)
ZA (1) ZA852854B (OSRAM)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
ATE87938T1 (de) * 1985-04-11 1993-04-15 Hoechst Ag Hirudin-derivat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3689525D1 (de) * 1985-07-17 1994-02-24 Hoechst Ag Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel.
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
WO1989011290A1 (en) * 1988-05-27 1989-11-30 Magainin Sciences, Inc. Amphiphilic peptides and use thereof
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
JPH07504152A (ja) * 1990-02-08 1995-05-11 マゲイニン ファーマスーティカルズ, インコーポレーテッド 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
EP0533795A4 (en) * 1990-05-14 1993-10-20 Magainin Sciences, Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
JPH05507718A (ja) * 1990-06-27 1993-11-04 マゲイニン サイエンセズ インコーポレーテッド 生物活性ペプチドおよびdnaギラーゼを阻害する抗生物質よりなる組成物と治療法
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
HUT63180A (en) * 1990-07-24 1993-07-28 Merrell Dow Pharma Process for producing anticoagulant peptides
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
JPH07500342A (ja) * 1991-10-16 1995-01-12 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 生物学的活性ペプチドおよび抗生物質を有する組成物およびこれを用いた治療
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
PT702696E (pt) * 1993-06-11 2003-12-31 Merrell Pharma Inc Peptidos trifuncionais antitrombina e antiplaquetas
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69624087T2 (de) 1996-01-31 2003-06-05 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
AU2009316828A1 (en) * 2008-11-19 2011-07-07 Avantor Performance Materials, Inc. New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341417C (fr) * 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
IE850983L (en) 1985-10-18
JPS60233098A (ja) 1985-11-19
ES8605772A1 (es) 1985-12-16
ES542310A0 (es) 1985-12-16
DK173985D0 (da) 1985-04-17
DK173985A (da) 1985-10-19
CA1271298A (en) 1990-07-03
DE3438296A1 (de) 1985-11-07
ZA852854B (en) 1985-11-27
KR850007801A (ko) 1985-12-09
JP2552263B2 (ja) 1996-11-06
AU4136485A (en) 1985-10-24
PT80301A (de) 1985-05-01
ES542309A0 (es) 1985-12-16
EP0158986A2 (de) 1985-10-23
ES8605770A1 (es) 1985-12-16
GR850942B (OSRAM) 1985-11-25
PT80301B (de) 1987-02-10
FI851521L (fi) 1985-10-19
NO851535L (no) 1985-10-21
HUT37806A (en) 1986-02-28
KR930000054B1 (ko) 1993-01-06
US4668662A (en) 1987-05-26
DE3587576D1 (de) 1993-10-21
ES542311A0 (es) 1985-12-16
IL74948A0 (en) 1985-08-30
IL74948A (en) 1989-09-10
DK171824B1 (da) 1997-06-23
IE60581B1 (en) 1994-07-27
FI851521A7 (fi) 1985-10-19
EP0158986A3 (en) 1988-09-21
FI851521A0 (fi) 1985-04-16
AU580295B2 (en) 1989-01-12
EP0158986B1 (de) 1993-09-15
HU198085B (en) 1989-07-28
AR242800A1 (es) 1993-05-31

Similar Documents

Publication Publication Date Title
ES8605771A1 (es) Procedimiento para preparar un polipeptido
ES8600216A1 (es) Un procedimiento para preparar octapeptidos lineales
ES8401015A1 (es) Un metodo de preparacion de un peptido.
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
ES8205754A1 (es) Procedimiento de preparacion de un nuevo ester octapeptido
ES2137182T3 (es) Derivados recombinantes del factor viii humano.
ES8401753A1 (es) Un procedimiento para la preparacion de un peptido inhibidor de la renina.
DK0642581T3 (da) Clostridium perfringens-vacciner
MX9207334A (es) Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
ES2059356T3 (es) Inhibidor de la tripsina pancreatico secretor, preparado mediante tecnologia genetica y sus variantes.
ES2032888T3 (es) Productos conservados para la limpieza del cabello y el cuerpo y utilizacion de una combinacion de sustancias conservantes.
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
ES8103027A1 (es) Un procedimiento para la preparacion de un polipeptido
ES8704957A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES8407012A1 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
ES8103026A1 (es) Un procedimiento para la preparacion de un peptido
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
ES8701785A1 (es) Un procedimiento para preparar un peptido ciclico basico conactividad antagonista de v1-vasopresina y oxitocina
ES2083805T3 (es) Purificacion de oxido de propileno.
ES2061759T3 (es) Amidas de acidos ciclometilen-1,2-dicarboxilicos con actividad terapeutica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES8201954A1 (es) Un metodo para la preparacion de derivados del acido prope- noico.
ES8506599A1 (es) Un procedimiento para preparar heptapeptidos y hexapeptidos ciclicos antagonistas de la vasopresina
GB1003176A (en) Butyl ethers of hydroxy amino acids and peptides and derivatives thereof
DK270489A (da) Protein med thrombininhiberende virkning, fremgangsmaade til dets isolering, samt dets anvendelse som laegemiddel

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506